Alemán-Contreras, R.; Gómez-Díaz, R.A.; Noyola-García, M.E.; Mondragón-González, R.; Wacher, N.; Ferreira-Hermosillo, A.
Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA. Life 2024, 14, 550.
https://doi.org/10.3390/life14050550
AMA Style
Alemán-Contreras R, Gómez-Díaz RA, Noyola-García ME, Mondragón-González R, Wacher N, Ferreira-Hermosillo A.
Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA. Life. 2024; 14(5):550.
https://doi.org/10.3390/life14050550
Chicago/Turabian Style
Alemán-Contreras, Ricardo, Rita A. Gómez-Díaz, Maura E. Noyola-García, Rafael Mondragón-González, Niels Wacher, and Aldo Ferreira-Hermosillo.
2024. "Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA" Life 14, no. 5: 550.
https://doi.org/10.3390/life14050550
APA Style
Alemán-Contreras, R., Gómez-Díaz, R. A., Noyola-García, M. E., Mondragón-González, R., Wacher, N., & Ferreira-Hermosillo, A.
(2024). Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA. Life, 14(5), 550.
https://doi.org/10.3390/life14050550